Discrimination of metabolic profiles of pancreatic cancer from chronic pancreatitis by high‐resolution magic angle spinning 1H nuclear magnetic resonance and principal components analysis
Open Access
- 28 August 2007
- journal article
- carcinogenesis
- Published by Wiley in Cancer Science
- Vol. 98 (11) , 1678-1682
- https://doi.org/10.1111/j.1349-7006.2007.00589.x
Abstract
The metabolic profiles of Sprague–Dawley rat pancreases were investigated by high‐resolution magic angle spinning proton magnetic resonance spectroscopy (1H NMR) combined with principal components analysis (PCA) to discriminate pancreatic cancer from chronic pancreatitis. Intact pancreatic tissue samples were obtained from Sprague–Dawley rats with histologically proven pancreatic cancer (n = 5), chronic pancreatitis (n = 5), and two matched controls (n = 5 per group). Two 1H NMR experiments, single‐pulse and Carr–Purcell–Meiboom–Gill, were carried out separately. Increases in phosphocholine and glycerophosphocholine levels and decreases in leucine, isoleucine, valine, lactate and alanine levels were observed in chronic pancreatitis, whereas the opposite trends were observed in pancreatic cancer. Increasing taurine and decreasing betaine were found both in chronic pancreatitis and in pancreatic cancer. Additionally, the lipid content in pancreatic cancer was higher than that in chronic pancreatitis. PCA was carried out for the single‐pulse and Carr–Purcell–Meiboom–Gill 1H NMR spectra, respectively, to visualize separation among the samples and to extract characteristic metabolites of pancreatic cancer and chronic pancreatitis. Decreased phosphocholine and glycerophosphocholine were suggested as unique metabolite indicators of pancreatic cancer. Furthermore, even with the disturbance of various quantities of lipid contents pancreatic cancer and chronic pancreatitis could be differentiated well by the combination of high‐resolution magic angle spinning 1H NMR and PCA. Thus this combination was demonstrated to have the potential to improve magnetic resonance spectroscopy for positive early diagnosis of pancreatic cancer in clinical settings. (Cancer Sci 2007; 98: 1678–1682)This publication has 25 references indexed in Scilit:
- Quantification of phosphocholine and glycerophosphocholine with31P edited1H NMR spectroscopyNMR in Biomedicine, 2005
- Visualizing metabolic changes in breast‐cancer tissue using 1H‐NMR spectroscopy and self‐organizing mapsNMR in Biomedicine, 2003
- An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck regionHead & Neck, 2002
- Choline containing metabolites during cell transfection: an insight into magnetic resonance spectroscopy detectable changesFEBS Letters, 2001
- Pattern recognition methods and applications in biomedical magnetic resonanceProgress in Nuclear Magnetic Resonance Spectroscopy, 2001
- Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopyNeuro-Oncology, 2000
- High resolution magic angle spinning 1H nuclear magnetic resonance analysis of intact prostatic hyperplastic and tumour tissuesAnalytical Communications, 1998
- Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic‐angle spinningMagnetic Resonance in Medicine, 1996
- In vivo 1H MRS choline: Correlation with in vitro chemistry/histologyLife Sciences, 1996
- Quantitative proton spectroscopy of canine brain: in Vivo and in Vitro correlationsMagnetic Resonance in Medicine, 1994